These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3839056)

  • 1. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative.
    Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP
    Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
    Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
    Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
    Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
    Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
    J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
    Bourgoin S; Le Bars D; Artaud F; Clot AM; Bouboutou R; Fournie-Zaluski MC; Roques BP; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1986 Jul; 238(1):360-6. PubMed ID: 3459871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
    Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
    Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP
    J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
    Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
    Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
    Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
    Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
    Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
    Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
    Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
    Hazato T; Kase R; Ueda H; Takagi H; Katayama T
    Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sexual behavior in female rats by intracerebral injections of Met-enkephalin in combination with an inhibitor of enkephalin degrading enzymes.
    Bednar I; Forsberg G; Södersten P
    Neurosci Lett; 1987 Aug; 79(3):341-5. PubMed ID: 3658224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
    Shimamura M; Kawamuki K; Hazato T
    J Neurochem; 1987 Aug; 49(2):536-40. PubMed ID: 3037031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.
    Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR
    Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.